209 related articles for article (PubMed ID: 32479684)
1. Omentin-1 attenuates adipose tissue inflammation via restoration of TXNIP/NLRP3 signaling in high-fat diet-induced obese mice.
Zhou H; Zhang Z; Qian G; Zhou J
Fundam Clin Pharmacol; 2020 Dec; 34(6):721-735. PubMed ID: 32479684
[TBL] [Abstract][Full Text] [Related]
2. Chikusetsu saponin IVa ameliorates high fat diet-induced inflammation in adipose tissue of mice through inhibition of NLRP3 inflammasome activation and NF-κB signaling.
Yuan C; Liu C; Wang T; He Y; Zhou Z; Dun Y; Zhao H; Ren D; Wang J; Zhang C; Yuan D
Oncotarget; 2017 May; 8(19):31023-31040. PubMed ID: 28415686
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Thioredoxin-Interacting Protein (TXNIP) Abrogates High Fat Diet-induced Retinal Leukostasis, Barrier Dysfunction and Microvascular Degeneration in a Mouse Obesity Model.
Mohamed IN; Sheibani N; El-Remessy AB
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492941
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies.
Greulich S; Chen WJ; Maxhera B; Rijzewijk LJ; van der Meer RW; Jonker JT; Mueller H; de Wiza DH; Floerke RR; Smiris K; Lamb HJ; de Roos A; Bax JJ; Romijn JA; Smit JW; Akhyari P; Lichtenberg A; Eckel J; Diamant M; Ouwens DM
PLoS One; 2013; 8(3):e59697. PubMed ID: 23555749
[TBL] [Abstract][Full Text] [Related]
5. 14-Deoxygarcinol improves insulin sensitivity in high-fat diet-induced obese mice via mitigating NF-κB/Sirtuin 2-NLRP3-mediated adipose tissue remodeling.
Chen JL; Feng ZL; Zhou F; Lou RH; Peng C; Ye Y; Lin LG
Acta Pharmacol Sin; 2023 Feb; 44(2):434-445. PubMed ID: 35945312
[TBL] [Abstract][Full Text] [Related]
6. Effects of Vitamin D Supplementation on Adipose Tissue Inflammation and NF-κB/AMPK Activation in Obese Mice Fed a High-Fat Diet.
Chang E
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142842
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue-derived omentin-1 attenuates arterial calcification via AMPK/Akt signaling pathway.
Xu F; Li FX; Lin X; Zhong JY; Wu F; Shan SK; Tan CM; Yuan LQ; Liao XB
Aging (Albany NY); 2019 Oct; 11(20):8760-8776. PubMed ID: 31659144
[TBL] [Abstract][Full Text] [Related]
8. The potential of adipokines as therapeutic agents for cardiovascular disease.
Shibata R; Ohashi K; Murohara T; Ouchi N
Cytokine Growth Factor Rev; 2014 Aug; 25(4):483-7. PubMed ID: 25066649
[TBL] [Abstract][Full Text] [Related]
9. The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: evidence from translational studies.
Salvoza N; Giraudi P; Gazzin S; Bonazza D; Palmisano S; de Manzini N; Zanconati F; Raseni A; Sirianni F; Tiribelli C; Rosso N
J Transl Med; 2023 Dec; 21(1):906. PubMed ID: 38082368
[TBL] [Abstract][Full Text] [Related]
10. Adipogenic miR-27a in adipose tissue upregulates macrophage activation via inhibiting PPARγ of insulin resistance induced by high-fat diet-associated obesity.
Yao F; Yu Y; Feng L; Li J; Zhang M; Lan X; Yan X; Liu Y; Guan F; Zhang M; Chen L
Exp Cell Res; 2017 Jun; 355(2):105-112. PubMed ID: 28365247
[TBL] [Abstract][Full Text] [Related]
11. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues.
Nway NC; Sitticharoon C; Chatree S; Maikaew P
Obes Res Clin Pract; 2016; 10(3):256-63. PubMed ID: 26067914
[TBL] [Abstract][Full Text] [Related]
12. A novel adipocytokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through antioxidative mechanism.
Kazama K; Okada M; Yamawaki H
Am J Physiol Heart Circ Physiol; 2014 Jun; 306(12):H1714-9. PubMed ID: 24727494
[TBL] [Abstract][Full Text] [Related]
13. Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment.
Zhao L; Kang I; Fang X; Wang W; Lee MA; Hollins RR; Marshall MR; Chung S
Int J Obes (Lond); 2015 Mar; 39(3):438-46. PubMed ID: 25042861
[TBL] [Abstract][Full Text] [Related]
14. Omentin-1 protects against bleomycin-induced acute lung injury.
Zhou Y; Hao C; Li C; Huang X; Li X; Tang Y; Huang Y; Tang S; Liu W; Feng D; Xu J; Yue S; Xie H; Luo Z
Mol Immunol; 2018 Nov; 103():96-105. PubMed ID: 30245266
[TBL] [Abstract][Full Text] [Related]
15. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells.
Zhang YY; Zhou LM
Eur J Pharmacol; 2013 Jan; 698(1-3):137-44. PubMed ID: 23178529
[TBL] [Abstract][Full Text] [Related]
16. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
18. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement.
Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q
Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788
[TBL] [Abstract][Full Text] [Related]
19. Txnip mediates glucocorticoid-activated NLRP3 inflammatory signaling in mouse microglia.
Bharti V; Tan H; Zhou H; Wang JF
Neurochem Int; 2019 Dec; 131():104564. PubMed ID: 31586460
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide controls adipose tissue inflammation associated with high-fat diet-induced obesity in mice.
Nakamitsu PZ; Compri CM; de Fraia Pinto L; Gotardo ÉM; de Oliveira CC; Ribeiro ML; Pedrazzoli J; Gambero A
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):151-8. PubMed ID: 25441253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
